Nav: Home

Decades of type 1 diabetes linked to mild drop in cognition

June 05, 2018

BOSTON - (June 5, 2018) - People who live with type 1 diabetes for very long duration show signs of mild decreases in cognitive abilities, primarily in memory, compared to those who don't have the disease, Joslin Diabetes Center researchers have shown.

The study compared Joslin 50-year Medalists, who have lived successfully with type 1 diabetes for at least that long, with other people of similar age with type 2 diabetes or without diabetes, says Gail Musen, PhD, an assistant investigator in Joslin's Research Division. The work is the first to evaluate whether cognitive function is changing in an aging group of people who have successfully managed their type 1 diabetes, a very complex disease associated with many complications, for from 50 to more than 80 years.

The mild cognitive declines don't appear in clinical signs for these Medalists, who remain in the normal range of function for people their age, emphasizes Musen, who is lead author on the paper about the work published in Diabetes Care.

Joslin investigators also examined how various measures of cognitive health among these Medalists might correspond to common diabetes complications. Most strikingly, "the memory changes are associated with cardiovascular disease," says Hillary Keenan, PhD, a former principal investigator on the Medalist study and corresponding author on the paper.

The scientists tested and compared cognition in 82 Medalists, 31 age-matched individuals with type 2 diabetes and 30 age-matched non-diabetic controls. Their investigation included standard tests for memory, psychomotor speed and executive function (higher cognitive processes involved in decision-making).

The memory tests required participants to recall a list of words immediately after presentation as well as after a 30-minute delay. Performance was significantly but not dramatically lower in people with either form of diabetes than in people lacking the disease. While this has been known for people with type 2 diabetes, the changes in memory in aging people with type 1 diabetes had not been clearly established.

In the psychomotor test, the researchers looked at how quickly and well subjects inserted small key-shaped pegs into similarly shaped slots that have been rotated to require fine motor dexterity. Medalists on average performed slightly worse than those without diabetes. This diminished performance was associated with proliferative diabetic retinopathy, an advanced form of eye disease. (However, it didn't reflect poorer vision, since Medalists wore their corrective lenses.)

The executive-function test scored how quickly and accurately participants put scrambled letters and numbers into a given order. Here the Joslin team also saw a tendency of slightly worse results among Medalists than their peers without diabetes.

"Overall, nobody among the Medalists needs to worry; this is a very healthy group that's showing minimal signs of cognitive decline," Musen stresses. "However, these small deficits may be avoidable with self-care behaviors that help minimize diabetes complications."

Previous research on the Medalists has consistently found that moderate physical exercise is linked to a reduction in cardiovascular disease. The latest findings provide yet another incentive for people with type 1 diabetes to pursue physical exercise, in addition to following general guidelines for healthcare and diabetes management, says Keenan.

With the incidence of type 1 diabetes on the rise, Joslin continues to examine the long-term effects of the disease on cognition and other complications, says George King, MD, Joslin's Chief Scientific Officer and Director of Research Division. "We want to further study this population, to better understand these processes and find therapies to protect against them," he says. "Since both eye and cardiovascular diseases in diabetic patients are treatable, we are very hopeful the cognitive decline in type 1 diabetes is also preventable."
-end-
Co-authors on the paper include Liane Tinsley, David Pober, Jennifer Sun, Maya Khatri, Richie Huynh and Annie Lu of Joslin, along with Katrina Marcinkowski of Eastern Virginia Medical School. Funding came from the National Institute of Diabetes and Digestive and Kidney Diseases, and contributions by Tom Beatson and many other Joslin Medalists.

Joslin Diabetes Center

Related Diabetes Articles:

The role of vitamin A in diabetes
There has been no known link between diabetes and vitamin A -- until now.
Can continuous glucose monitoring improve diabetes control in patients with type 1 diabetes who inject insulin
Two studies in the Jan. 24/31 issue of JAMA find that use of a sensor implanted under the skin that continuously monitors glucose levels resulted in improved levels in patients with type 1 diabetes who inject insulin multiple times a day, compared to conventional treatment.
Complications of type 2 diabetes affect quality of life, care can lead to diabetes burnout
T2D Lifestyle, a national survey by Health Union of more than 400 individuals experiencing type 2 diabetes (T2D), reveals that patients not only struggle with commonly understood complications, but also numerous lesser known ones that people do not associate with diabetes.
Type 2 diabetes and obesity -- what do we really know?
Social and economic factors have led to a dramatic rise in type 2 diabetes and obesity around the world.
A better way to predict diabetes
An international team of researchers has discovered a simple, accurate new way to predict which women with gestational diabetes will develop type 2 diabetes after delivery.
More Diabetes News and Diabetes Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Erasing The Stigma
Many of us either cope with mental illness or know someone who does. But we still have a hard time talking about it. This hour, TED speakers explore ways to push past — and even erase — the stigma. Guests include musician and comedian Jordan Raskopoulos, neuroscientist and psychiatrist Thomas Insel, psychiatrist Dixon Chibanda, anxiety and depression researcher Olivia Remes, and entrepreneur Sangu Delle.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...